Author

T.-C. Lai

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

C.-J. Yang· 1 shared C.-W. Lee· 1 shared I.-S. Yu· 1 shared I.-T. Lee· 1 shared J. Chiou· 1 shared M. Hsiao· 1 shared M.-S. Huang· 1 shared P. M.-H. Chang· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C.-J. Yang

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MiR-221/222-enriched ADSC-exosome mitigates PM exposure-exacerbated cardiac ischemia/reperfusion injury through the modulation of the BNIP3/LC3B/PUMA pathway

T.-L. Lee, W.-C. Shen, Y.-C. Chen, T.-C. Lai, S.-R. Lin, S.-W. Lin, I.-S. Yu, Y.-H. Yeh, T.-K. Li, I.-T. Lee, C.-W. Lee, Y.-L. Chen

This study shows that PM exposure worsens cardiac ischemia/reperfusion injury, which is mitigated by ADSC-exosome containing miR-221/222 through modulation of the BNIP3/LC3B/PUMA pathway.

bioRxiv · Nov 10, 2023 · PreprintCell Biology

TAO Kinase 3 Overexpression Is a Poor Prognosis Marker for Lung Adenocarcinoma and Predicts Paclitaxel Resistance

P. M.-H. Chang, T.-C. Lai, Y.-C. Yang, Y.-C. Chang, J. Chiou, M.-S. Huang, C.-J. Yang, M. Hsiao

This study shows TAOK3 overexpression correlates with poor prognosis and paclitaxel resistance in lung adenocarcinoma, suggesting it as a therapeutic target.

bioRxiv · Apr 29, 2019 · PreprintCancer Biology